Drug intelligence / Profile preview

Spermoforte

Development stage: Unknown
Lead developer: Gynavista
Modality: Small Molecules
Administration: Oral

Overview

Spermoforte is a multi-ingredient nutraceutical supplement marketed by Gynavista for the management of male infertility. It is formulated as a finished pharmaceutical product designed to improve sperm parameters, including count, motility, and morphology. The product typically contains a combination of antioxidants, amino acids, and micronutrients such as L-carnitine, Coenzyme Q10, Zinc, and Lycopene. These components work synergistically to reduce oxidative stress within the seminal fluid, support mitochondrial energy production for sperm motility, and provide essential building blocks for healthy spermatogenesis. As a product of a pharma franchise company in India, it is commercially available for clinical use in reproductive medicine.

Brand names: Spermoforte

Beyond the preview

Go deeper on Spermoforte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spermoforte.

Explore the full profile